Scarica l'app Stockscreener
0.5486
0.25%
-0.0014
Pre-mercato:
.55
0.0014
+0.26%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRNS Giù?
Forum
Previsione
Frazionamento azionario
Marinus Pharmaceuticals Inc Borsa (MRNS) Ultime notizie
MARINUS PHARMACEUTICALS, INC. (NASDAQ: MRNS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Marinus Pharmaceuticals, Inc. Investors of Upcoming Deadline - ACCESS Newswire
Morgan Stanley's Strategic Acquisition of Marinus Pharmaceuticals Shares - GuruFocus.com
Vanguard Group Inc Reduces Holdings in Marinus Pharmaceuticals I - GuruFocus.com
MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marinus Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Marinus Pharmaceuticals director sells shares worth $869 - MSN
UPCOMING MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Marinus pharmaceuticals director sells shares for $864 - MSN
Marinus Pharmaceuticals (MRNS) Stock Price, News & Analysis - MarketBeat
Marinus pharmaceuticals director sells shares for $864 By Investing.com - Investing.com Canada
Immedica to buy Marinus Pharmaceuticals for $151m - MSN
Fragile X Syndrome Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Novartis, Neuren Pharma, Roche, Seaside Therapeutics, Inc., Marinus Pharma, Lysogene - Barchart
Fragile X Syndrome Market Predicted to See Upsurge Through 2034, - openPR
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of AE, MRNS, SASR, ROIC to Take Action - The Malaysian Reserve
Marinus plummets 78% as phase 3 interim analysis of ganaxolone disappoints - MSN
Marinus Pharmaceuticals (MRNS) Upgraded to Buy: Here's What You Should Know - MSN
Beryl Capital Management LLC Acquires Significant Stake in Marin - GuruFocus.com
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Marinus Pharmaceuticals, Inc.MRNS - Kilgore News Herald
Immedica Pharma AB’s Acquisition of Marinus Pharmaceuticals - Global Legal Chronicle
MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc.MRNS - Business Wire
Immedica acquires Marinus in $151 million deal - The Pharma Letter
Marinus Therapeutics in Radnor Acquired by Swedish Company - MSN
Immedica Pharma to Acquire Marinus Pharmaceuticals in $151 Million Deal - MSN
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRNS, VCSA, MHLD on Behalf of Shareholders - Marketscreener.com
Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular - Citeline News & Insights
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – VINC, VCSA, MRNS, MHLD - GlobeNewswire Inc.
Marinus executives in line for bonuses after acquisition deal triggers retention payouts - The Business Journals
After phase 3 setbacks, troubled Marinus inks $151M sale to Immedica Pharma - FiercePharma
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerVINC, VCSA, MRNS, MHLD - Stockhouse Publishing
Neutral rating reaffirmed for Marinus stock as acquisition deal closure nears - Investing.com Canada
Marinus Pharmaceuticals to be acquired by Immedica for 55c per share - Yahoo Finance
Immedica Pharma AB entered into definitive agreement to acquire Marinus Pharmaceuticals, Inc.. - Marketscreener.com
Orion and Marinus Terminate Agreement for ganaxolone in Europe - Marketscreener.com
Immedica to buy rare disease drugmaker Marinus for $151 million - Crain's Chicago Business
Immedica to acquire Marinus Pharmaceuticals for $151 million By Investing.com - Investing.com Canada
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Me - GuruFocus.com
Marinus Pharmaceuticals ends agreements with Orion Corporation By Investing.com - Investing.com Nigeria
Marinus Pharmaceuticals ends agreements with Orion Corporation - Investing.com India
Immedica Pharma AB entered into an agreement to acquire Marinus Pharmaceuticals, Inc.. - Marketscreener.com
Immedica to Acquire Marinus Pharmaceuticals in $151 Million Deal; Shares Surge 43% - GuruFocus.com
Marinus Pharma Agrees To $151 Million Acquisition By Immedica: Shares Surge Over 40% - Benzinga
0.82%
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):